Maxine Gowen - Net Worth and Insider Trading
Maxine Gowen Net Worth
The estimated net worth of Maxine Gowen is at least $36,303 dollars as of 2024-04-27. Maxine Gowen is the Director of Akebia Therapeutics Inc and owns about 24,133 shares of Akebia Therapeutics Inc (AKBA) stock worth over $32,338. Maxine Gowen is the President & CEO of Trevena Inc and owns about 10,140 shares of Trevena Inc (TRVN) stock worth over $3,965. Maxine Gowen is also the Director of Aceragen Inc and owns about 0 shares of Aceragen Inc (ACGN) stock worth over $0. Details can be seen in Maxine Gowen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Maxine Gowen has not made any transactions after 2023-08-10 and currently still holds the listed stock(s).
Transaction Summary of Maxine Gowen
Maxine Gowen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Maxine Gowen owns 6 companies in total, including Akebia Therapeutics Inc (AKBA) , Aclaris Therapeutics Inc (ACRS) , and Trevena Inc (TRVN) among others .
Click here to see the complete history of Maxine Gowen’s form 4 insider trades.
Insider Ownership Summary of Maxine Gowen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AKBA | Akebia Therapeutics Inc | 2020-06-08 | director |
| ACRS | Aclaris Therapeutics Inc | 2019-07-02 | director |
| TRVN | Trevena Inc | 2019-02-01 | director & President & CEO |
| ACGN | Aceragen Inc | 2023-08-10 | director |
| MRUS | Merus NV | 2021-05-28 | director |
| PASG | Passage Bio Inc | 2021-02-18 | director |
Maxine Gowen Latest Holdings Summary
Maxine Gowen currently owns a total of 3 stocks. Among these stocks, Maxine Gowen owns 24,133 shares of Akebia Therapeutics Inc (AKBA) as of June 8, 2020, with a value of $32,338 and a weighting of 89.08%. Maxine Gowen owns 10,140 shares of Trevena Inc (TRVN) as of February 1, 2019, with a value of $3,965 and a weighting of 10.92%. Maxine Gowen also owns 0 shares of Aceragen Inc (ACGN) as of August 10, 2023, with a value of $0 and a weighting of 0%.
Latest Holdings of Maxine Gowen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics Inc | 2020-06-08 | 24,133 | 1.34 | 32,338 |
| TRVN | Trevena Inc | 2019-02-01 | 10,140 | 0.39 | 3,965 |
| ACGN | Aceragen Inc | 2023-08-10 | 0 | 0.38 | 0 |
Holding Weightings of Maxine Gowen
Maxine Gowen Form 4 Trading Tracker
According to the SEC Form 4 filings, Maxine Gowen has made a total of 1 transactions in Akebia Therapeutics Inc (AKBA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Akebia Therapeutics Inc is the sale of 4,567 shares on June 8, 2020, which brought Maxine Gowen around $55,032.
According to the SEC Form 4 filings, Maxine Gowen has made a total of 0 transactions in Trevena Inc (TRVN) over the past 5 years. The most-recent trade in Trevena Inc is the acquisition of 2,000 shares on February 1, 2019, which cost Maxine Gowen around $51,000.
According to the SEC Form 4 filings, Maxine Gowen has made a total of 1 transactions in Aceragen Inc (ACGN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Aceragen Inc is the sale of 51 shares on August 10, 2023, which brought Maxine Gowen around $26.
Insider Trading History of Maxine Gowen
- 1
Maxine Gowen Trading Performance
GuruFocus tracks the stock performance after each of Maxine Gowen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Maxine Gowen is 24.66%. GuruFocus also compares Maxine Gowen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Maxine Gowen within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Maxine Gowen's insider trading performs compared to the benchmark.
Performance of Maxine Gowen
Average Return
-36.79%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.93 | 24.66 | -11.49 | -36.79 | -22.42 | -38.58 |
| Relative Return to S&P 500(%) | 2.76 | 18.8 | -20.56 | -55.07 | -38.22 | -51.8 |
Maxine Gowen Ownership Network
Ownership Network List of Maxine Gowen
Ownership Network Relation of Maxine Gowen
Maxine Gowen Owned Company Details
What does Akebia Therapeutics Inc do?
Who are the key executives at Akebia Therapeutics Inc?
Maxine Gowen is the director of Akebia Therapeutics Inc. Other key executives at Akebia Therapeutics Inc include SVP & Chief Business Officer Michel Dahan , SVP & Chief Medical Officer Steven Keith Burke , and director & CEO & President John P. Butler .
Akebia Therapeutics Inc (AKBA) Insider Trades Summary
Over the past 18 months, Maxine Gowen made no insider transaction in Akebia Therapeutics Inc (AKBA). Other recent insider transactions involving Akebia Therapeutics Inc (AKBA) include a net sale of 145,385 shares made by Michel Dahan , a net sale of 100,765 shares made by Steven Keith Burke , and a net sale of 96,282 shares made by Nicole R. Hadas .
In summary, during the past 3 months, insiders sold 132,629 shares of Akebia Therapeutics Inc (AKBA) in total and bought 0 shares, with a net sale of 132,629 shares. During the past 18 months, 635,551 shares of Akebia Therapeutics Inc (AKBA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 635,551 shares.
Akebia Therapeutics Inc (AKBA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Akebia Therapeutics Inc Insider Transactions
Maxine Gowen Mailing Address
Above is the net worth, insider trading, and ownership report for Maxine Gowen. Currently GuruFocus does not have mailing address information for Maxine Gowen.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
